4153 logo

DIVA Laboratories, Ltd. Stock Price

TPEX:4153 Community·NT$2.0b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

4153 Share Price Performance

NT$33.95
-6.35 (-15.76%)
NT$33.95
-6.35 (-15.76%)
Price NT$33.95

4153 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet and slightly overvalued.

2 Risks
1 Reward

DIVA Laboratories, Ltd. Key Details

NT$868.8m

Revenue

NT$604.7m

Cost of Revenue

NT$264.1m

Gross Profit

NT$173.6m

Other Expenses

NT$90.5m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
1.54
30.40%
10.42%
0%
View Full Analysis

About 4153

Founded
1995
Employees
n/a
CEO
Chen Gene
WebsiteView website
www.diva.com.tw

DIVA Laboratories, Ltd. engages in the development, manufacture, and sale of medical equipment and computer related devices worldwide. The company provides endo/surgical displays, a static and dynamic image for hybrid and integrated ORs applications; color and mono displays for radiology and medical imaging applications; touch displays/human machine interface products; medical and industrial cases; and displays to original design manufacturers (ODM) and original equipment manufacturers (OEMs) customers. It also offers emergency room/ operating room, diagnostic equipment, and clinic display solutions. DIVA Laboratories, Ltd. was incorporated in 1995 and is headquartered in New Taipei City, Taiwan.

Recent 4153 News & Updates

Recent updates

No updates